{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:33:00Z","timestamp":1778049180457,"version":"3.51.4"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Metformin-associated lactic acidosis (MALA) is a rare but serious adverse event. It is associated with a high mortality rate and is diagnosed by the peak lactate level (PLL). This study examines the relationship between the clinical presentations and PLL in patients under metformin therapy admitted to the intensive care unit (ICU) to better diagnose MALA and prevent a worsening prognosis. The mortality distribution of clinical characteristics among patients with MALA was also examined.<\/jats:p>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We retrospectively analyzed 82 adult patients with MALA admitted to the ICU over 20 years. The association between the clinical parameters and mortality post-MALA was estimated using logistic regression analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Patients with MALA admitted to the ICU presented with clinical symptoms mainly associated with the head (40.24%), chest (41.46%), and abdomen (35.37%). Additionally, the PLL distribution significantly varied with age, APACHE II = Acute Physiology and Chronic Health Evaluation II (APACHE II) score, various laboratory parameters like nadir arterial bicarbonate level, multiple treatment modalities such as renal replacement therapy, and mortality. The overall mortality rate was 17.07%. After adjustment of age and gender, the significant predictors of mortality were APACHE II score, PLL, vasoactive support, ventilator support, and cardiopulmonary resuscitation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Despite MALA being a rare event, it is necessary to evaluate its clinical characteristics, especially the associated PLL and mortality. In the current study, higher levels of APACHE II score and PLL show a greater likelihood of mortality in MALA patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000029918","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T12:06:50Z","timestamp":1657282010000},"page":"e29918","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Clinical presentations and prognosis of metformin-associated lactic acidosis patients in the intensive care unit: A 20-year survey"],"prefix":"10.1097","volume":"101","author":[{"given":"Chun-Chieh","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Intensive Care Medicine, Chi Mei Medical Center, Tainan, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Feng","family":"Weng","sequence":"additional","affiliation":[{"name":"Department of Healthcare Administration and Medical Informatics, Kaohsiung Medical University, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuei-Ling","family":"Tseng","sequence":"additional","affiliation":[{"name":"Department of Respiratory Therapy, Chi Mei Medical Center, Tainan, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5925-8477","authenticated-orcid":false,"given":"Chung-Han","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Medical Research, Chi Mei Medical Center, Tainan, Taiwan"},{"name":"Department of Information Management, Southern Taiwan University of Science and Technology, Tainan, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: from mechanisms of action to therapies.","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metab"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-137-1-200207020-00009","article-title":"Metformin: an update.","volume":"137","author":"Kirpichnikov","year":"2002","journal-title":"Ann Intern Med"},{"key":"R3-20250504","first-page":"4059","article-title":"Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.","volume":"81","author":"Cusi","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain.","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem J"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/CCM.0b013e3181a02490","article-title":"Metformin-associated lactic acidosis: a prognostic and therapeutic study.","volume":"37","author":"Seidowsky","year":"2009","journal-title":"Crit Care Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM199801223380415","article-title":"Lactic acidosis in patients with diabetes treated with metformin.","volume":"338","author":"Misbin","year":"1998","journal-title":"N Engl J Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/00002018-199920040-00006","article-title":"Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations.","volume":"20","author":"Lalau","year":"1999","journal-title":"Drug Saf"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1001\/archinte.1992.00400230129023","article-title":"Biguanide-associated lactic acidosis. Case report and review of the literature.","volume":"152","author":"Gan","year":"1992","journal-title":"Arch Intern Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"R1491","DOI":"10.1186\/cc7137","article-title":"Metformin-associated lactic acidosis in an intensive care unit.","volume":"12","author":"Peters","year":"2008","journal-title":"Crit Care"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s13181-019-00755-6","article-title":"Do patients die with or from metformin-associated lactic acidosis (MALA)? Systematic review and meta-analysis of pH and lactate as predictors of mortality in MALA.","volume":"16","author":"Blumenberg","year":"2020","journal-title":"J Med Toxicol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00134-018-5213-x","article-title":"The ten pitfalls of lactate clearance in sepsis.","volume":"45","author":"Hernandez","year":"2019","journal-title":"Intensive Care Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3390\/diagnostics10121105","article-title":"Failure of lactate clearance predicts the outcome of critically ill septic patients.","volume":"10","author":"Bruno","year":"2020","journal-title":"Diagnostics"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/2110-5820-3-12","article-title":"Clinical use of lactate monitoring in critically ill patients.","volume":"3","author":"Bakker","year":"2013","journal-title":"Ann Intensive Care"},{"key":"R14-20250504","first-page":"191","article-title":"Metformin-associated lactic acidosis (MALA): clinical profile and outcomes in patients admitted to the intensive care unit.","volume":"12","author":"Biradar","year":"2010","journal-title":"Crit Care Resusc"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40620-016-0267-8","article-title":"Metformin associated lactic acidosis (MALA): clinical profiling and management.","volume":"29","author":"Moioli","year":"2016","journal-title":"J Nephrol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum likelihood estimates.","volume":"80","author":"Firth","year":"1993","journal-title":"Biometrika"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/sim.3794","article-title":"Bias-reduced and separation-proof conditional logistic regression with small or sparse data sets.","volume":"29","author":"Heinze","year":"2010","journal-title":"Stat Med"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/ndt\/12.5.1046","article-title":"Bicarbonate haemodialysis as a treatment of metformin overdose.","volume":"12","author":"Heaney","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.143.3613.1457","article-title":"Excess lactate: an index of reversibility of shock in human patients.","volume":"143","author":"Broder","year":"1964","journal-title":"Science"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1046\/j.1365-2044.1998.436-az0549.x","article-title":"The management of metformin overdose.","volume":"53","author":"Teale","year":"1998","journal-title":"Anaesthesia"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/15563650.2013.860985","article-title":"Metformin accumulation: lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy.","volume":"52","author":"Vecchio","year":"2014","journal-title":"Clin Toxicol (Phila)"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"e239154","DOI":"10.1136\/bcr-2020-239154","article-title":"Metformin-associated lactic acidosis.","volume":"14","author":"Fadden","year":"2021","journal-title":"BMJ Case Rep"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"bcr2017221686","DOI":"10.1136\/bcr-2017-221686","article-title":"Metformin-associated lactic acidosis mimicking ischaemic bowel.","volume":"2018","author":"Ali","year":"2018","journal-title":"BMJ Case Rep"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s40800-018-0076-1","article-title":"Metformin-associated lactic acidosis: a case report.","volume":"5","author":"Umeda","year":"2018","journal-title":"Drug Saf Case Rep"},{"key":"R25-20250504","first-page":"e5330","article-title":"Metformin-associated lactic acidosis successfully treated with continuous renal replacement therapy.","volume":"11","author":"Deepak","year":"2019","journal-title":"Cureus"},{"key":"R26-20250504","first-page":"252","article-title":"Metformin-associated lactic acidosis developed as a result of a suicidal attempt.","volume":"54","author":"Vural","year":"2020","journal-title":"Med Bul Sisli Etfal Hosp"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12882-022-02781-z","article-title":"A patient with severe metformin-associated lactic acidosis complicated by acute coronary syndrome: a case report.","volume":"23","author":"Mammadova","year":"2022","journal-title":"BMC Nephrol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.annemergmed.2009.04.023","article-title":"Acute metformin overdose: examining serum pH, lactate level, and metformin concentrations in survivors versus nonsurvivors: a systematic review of the literature.","volume":"54","author":"Dell\u2019Aglio","year":"2009","journal-title":"Ann Emerg Med"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000471917","article-title":"Metformin-associated lactic acidosis undergoing renal replacement therapy in intensive care units: a five-million population-based study in the North-West of Italy.","volume":"44","author":"Mariano","year":"2017","journal-title":"Blood Purif"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-017-0640-4","article-title":"Serum lactate level and mortality in metformin-associated lactic acidosis requiring renal replacement therapy: a systematic review of case reports and case series.","volume":"18","author":"Yeh","year":"2017","journal-title":"BMC Nephrol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/dme.13098","article-title":"Lactic acidosis: relationship between metformin levels, lactate concentration and mortality.","volume":"33","author":"Boucaud-Maitre","year":"2016","journal-title":"Diabet Med"},{"key":"R32-20250504","first-page":"121","article-title":"Blood lactate and oxygen transport.","volume":"4","author":"Kruse","year":"1987","journal-title":"Intensive Care World"},{"key":"R33-20250504","first-page":"100S","article-title":"Definition of clinically significant lactic acidosis.","volume":"92","author":"Kruse","year":"1987","journal-title":"Chest"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/01.CIR.41.6.989","article-title":"Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock).","volume":"41","author":"Weil","year":"1970","journal-title":"Circulation"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJM199801013380106","article-title":"Management of life-threatening acid-base disorders. First of two parts.","volume":"338","author":"Adrogu\u00e9","year":"1998","journal-title":"N Engl J Med"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00003246-197303000-00003","article-title":"Quantitation of severity of critical illness with special reference to blood lactate.","volume":"1","author":"Cady","year":"1973","journal-title":"Crit Care Med"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0002-9343(87)90500-6","article-title":"Significance of blood lactate levels in critically ill patients with liver disease.","volume":"83","author":"Kruse","year":"1987","journal-title":"Am J Med"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/jama.1987.03400040095029","article-title":"Controversies in lactic acidosis: implications in critically III patients.","volume":"258","author":"Mizock","year":"1987","journal-title":"JAMA"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0889-8529(18)30163-4","article-title":"Lactic acidosis.","volume":"22","author":"Stacpoole","year":"1993","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2050-6511-14-22","article-title":"The prognostic value of blood pH and lactate and metformin concentrations in severe metformin-associated lactic acidosis.","volume":"14","author":"Kajbaf","year":"2013","journal-title":"BMC Pharmacol Toxicol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:04:11Z","timestamp":1746331451000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":40,"journal-issue":{"issue":"27","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029918","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]}}}